Change in Directorate
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kerala Ayurveda Ltd informed the stock exchange about board changes approved via circular resolution on 30 June 2025. The Board decided to continue Mr. Ramesh Vangal as Chairman and Non-Executive Non-Independent Director, and Mr. Anand Subramanian as Non-Executive Non-Independent Director, following the Supreme Court of Mauritius terminating liquidation proceedings against promoter Katra Holdings Ltd. The Board also appointed Mr. Saif Khan, a former YES BANK and PayNearby executive, as an Additional Non-Executive Independent Director for a five-year term. Notably, the filing reveals an ongoing NCLT petition filed by Mr. Ouma Shankar Ochit under Sections 241 & 242, with interim directions keeping the appointments of Vangal and Subramanian in abeyance, and the petitioner restrained from alienating shares pending proceedings. All changes remain subject to shareholder approval.
Mixed and potentially negative for shareholders: while the board is stabilising after the Mauritius court order, the active NCLT case and the cloud over promoter-linked directors signal ongoing governance and legal uncertainty. The appointment of an independent director with banking experience is a positive step, but investors should watch the NCLT outcome closely as it could affect board control and share-related restrictions.